What does Alkermes invest in?
Alkermes invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Medical, Personal Health and Biotechnology.
United States · Investor
Last cheque observed Aug 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietCorporate VC
2 rounds on record
Mostly Series B and Series C: 100% of its rounds
1 exits from the portfolio
Every round we can evidence, newest first2 appearances
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 21 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Companies it backed that were later bought or listed1 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Alkermes. A count of rooms they were both in, not a relationship either has claimed.
Alkermes invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Medical, Personal Health and Biotechnology.
2 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2014.
The median round it joins is $47M.
No investments in the last 12 months; the latest was in Aug 2014.
Most often Bay City Capital (2 rounds together), Canaan (2 rounds together) and Fountain Healthcare Partners (2 rounds together).
Alkermes is a corporate VC based in Dublin, United States.
Alkermes was founded in 1987.
From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it